Clinical Trials Directory

Trials / Completed

CompletedNCT02417688

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis

PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With [64]Cu-25%CANF-Comb

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

To demonstrate feasibility of imaging Cu\[64\]-25%-CANF-Comb uptake in the atherosclerosis of the carotid artery of patients for whom carotid artery endarterectomy surgery is planned in comparison to the carotid artery for which intervention is not planned.

Detailed description

This study is a single center, open-label baseline controlled imaging study designed to demonstrate feasibility of PET imaging of radiopharmaceutical nanoparticle Cu\[64\]-25%CANF-Comb uptake by PET-MR. Patients will undergo Cu\[64\]-25%CANF-Comb PET-MR imaging of both carotid arteries. Both carotid arteries will be imaged at the same time. We hope to demonstrate differences in PET SUV (Standardized Uptake Value) in the significantly atherosclerotic artery in patients who will be going to carotid endarterectomy surgery in comparison to the PET SUV in the artery that is not significantly diseased (ie; the artery that will not undergo surgery) . We also will determine whether PET SUV of the Cu\[64\]-25%CANF-Comb by the plaque correlates to the American Heart Association classifications of atherosclerosis and tissue presence of NPR-C in the ex vivo carotid endarterectomy specimen post surgery as measured by RT-PCR.

Conditions

Interventions

TypeNameDescription
DEVICECu[64]-25%-CANF-Comb PET-MRSingle IV injection of a novel radiopharmaceutical for diagnostic imaging of atherosclerosis by PET-MR

Timeline

Start date
2015-04-05
Primary completion
2021-04-30
Completion
2021-04-30
First posted
2015-04-16
Last updated
2022-10-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02417688. Inclusion in this directory is not an endorsement.